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randomised trial
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Abstract
Background: Recruitment rates in multi-centre randomised trials often fall below target recruitment rates, causing
problems for study outcomes. The Studies Within A Trial (SWAT) Programme, established by the All-Ireland Hub for
Trials Methodology Research in collaboration with the Medical Research Council Network of Hubs in the United
Kingdom and others, is developing methods for evaluating aspects of trial methodology through the conduct of
research within research. A recently published design for a SWAT-1 provides a protocol for evaluating the effect
of a site visit by the principal investigator on recruitment in multi-centre trials.
Methods: Using the SWAT-1 design, the effect of a site visit, with the sole purpose of discussing trial recruitment,
on recruitment rates in a large multicentre trial in the Republic of Ireland was evaluated. A controlled before and
after intervention comparison was used, where the date of the site visit provides the time point for the intervention,
and for the comparison to control sites. Site A received the intervention. Site B and Site C acted as the controls.
Z-scores for proportions were calculated to determine within site recruitment differences. Odds ratios and 95%
confidence intervals were calculated to determine between site recruitment differences.
Results: Recruitment rates were increased in Site A post-intervention (17% and 14% percentage point increases
at 1 and 3 months, respectively). No differences in recruitment occurred in Site B or in Site C. Comparing between
site differences, at 3 months post-intervention, a statistically significant difference was detected in favour of higher
recruitment in Site A (34% versus 25%; odds ratio 1.57, 95% confidence interval 1.09 to 2.26).
Conclusions: This is the first reported example of a study in the SWAT programme.. It provides evidence that a site
visit, combined with a scheduled meeting, increases recruitment in a clinical trial. Using this example, other researchers
might be encouraged to consider conducting a similar study, allowing the findings of future SWAT-1s to be compared
and combined, so that higher level evidence on the effect of a site visit by the principal investigator can be obtained.
The ADCAR trial: ISRCTN-96340041 (www.controlled-trials.com); date of registration: 25 March 2008.
Keywords: Study Within A Trial, SWAT-1, multi-centre randomised trials
Background
Recruitment in large multi-centre randomised trials in-
variably presents a challenge for the research team. Actual
recruitment rates often fall below those that were hoped
for at the start of the trial [1-3]. Poor or slow recruit-
ment causes problems for study outcomes, including a
reduction in the statistical power of the study, delays in
resolving the uncertainty that underpinned the need for
the trial [1-4] and potential resource wastage. The clinical
implication of an underpowered trial is the possibility that
the study findings will conclude erroneously that there is
no difference between the treatments under investigation
when in reality there is a difference. This erroneous con-
clusion has clinical significance whereby people may be
denied a potentially more effective treatment than that
which was previously offered [1,2]. Poor or slow recruit-
ment may also require extending the trial, which may lead
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to increased costs and implications for potential future
funding by the funding agency [1].
Faced with poor or slow recruitment, trial researchers
often undertake activities aimed strategically at improving
recruitment. Examples of these include increased commu-
nication between the researchers and the study sites [5],
incentives for trial recruiters or participants [6], modifi-
cation to the training given to the recruiters [7] and
modifications to the recruitment approach [8]. Respon-
sive activities might be implemented as a single activity
or as multiple activities at the same time. When the latter
occurs, it is often difficult to disentangle the activities that
may or may not improve recruitment rates in a trial.
Studies Within A Trial (SWAT) Programme
Established by the All-Ireland Hub for Trials Methodology
Research in collaboration with the Medical Research
Council Network of Hubs in the United Kingdom and
others, the SWAT (Studies Within A Trial) Programme
is developing methods for evaluating the effects of differ-
ent ways of designing, conducting, analysing and evalu-
ating studies through the conduct of research within
research [9]. The SWAT Programme is developing a
series of short outlines for studies within trials that will
be made available online for researchers to consider.
The first in the series, SWAT-1, provides a protocol for
evaluating the effects of site visits by the principal in-
vestigator on recruitment rates in multi-centre rando-
mised trials [10]. Using SWAT-1 methodology, in this
paper, we describe the effect of a site visit combined with
a scheduled meeting, with the sole purpose of discussing
recruitment, on recruitment rates in a multi-centre rando-
mised trial (the ADCAR trial) in the Republic of Ireland.
Aim
The aim of this study is to evaluate the effectiveness of a
site visit combined with a scheduled meeting, with the
sole purpose of discussing recruitment on recruitment
rates to the ADCAR trial.
Methods
Context for the SWAT-1
The ADCAR trial is a multi-centre, three-site rando-
mised trial that was conducted in the Republic of Ireland
between May 2008 and April 2012. ADCAR evaluated
the effectiveness of admission cardiotocography (ACTG)
versus intermittent auscultation (IA) of the fetal heart rate
(FHR) in low risk women on admission to the labour as-
sessment room with signs of possible labour. Based on
sample size estimates, a target study sample of 5,776 was
required, and it was anticipated that this could be achieved
within a 28-month recruitment time-frame. However, as
the trial progressed, monthly overall recruitment rates aver-
aged approximately one-third of target rates, with recruit-
ment in some sites proportionately better than in others.
Design
The study uses SWAT-1 methodology [10], with a con-
trolled before and after intervention comparison where
the date of the site visit provides the time point for the
intervention and for the comparison to control sites. The
study was retrospective in design whereby a decision was
made to map the pre- and post-intervention recruitment
rates to the site visit and scheduled meeting approximately
eight months after the intervention was implemented. For
quality in reporting our methods, we provide an assess-
ment of the methodological quality of our study using the
Cochrane Effective Practice and Organisation of Care
(EPOC) Group risk of bias criteria (Table 1). Site A was
chosen to receive the intervention because, although it
had previously been achieving monthly recruitment of
30-40% of its initial target, this had fallen considerably
in the months preceding the intervention to 25% or less
of the target. Site B and Site C did not receive the inter-
vention and acted as the controls.
Description of the intervention
The intervention consisted of a site visit by the lead re-
searcher, that is, the person responsible for the day-to-
Table 1 Cochrane Effective Practice and Organisation of Care (EPOC) risk of bias criteria
Risk of bias criterion Judgement Reason for judgement
Allocation sequence generation High risk Non-randomised method used
Allocation concealment High risk Controlled before and after study
Similarity in baseline outcome measurements High risk Although all sites had low recruitment prior to the intervention,
this was imbalanced across the sites
Similarity in baseline characteristics Low risk Similar recruitment processes across sites
Incomplete outcome data addressed Low risk No missing data
Knowledge of the allocated intervention Low risk Objective outcomes, not affected by knowledge of the intervention
Protection against contamination Low risk Allocation was by study site
Free from selective reporting Low risk All pre-specified outcomes are reported
Free from other risks of bias Unclear risk Possible risk from confounders
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day management of the trial, combined with a scheduled
meeting arranged with the sole purpose of discussing re-
cruitment rates to the trial. The clinical manager at Site
A was contacted with a request to facilitate the visit and
meeting. This included advertisement of the meeting 2
weeks in advance, targeting senior midwifery and obstet-
ric staff to attend the meeting and setting the meeting
date and time to facilitate maximum staff attendance.
The site visit took place on 22 June 2011. The meeting
consisted of a 10-minute presentation inclusive of infor-
mation on overall trial recruitment rates and site-specific
recruitment trends followed by 20 minutes of discussion
on challenges to recruitment and how these might be
overcome. Table 2 provides additional details on the inter-
vention meeting.
Description of control
The control sites (Site B and Site C) did not receive a
site visit combined with a scheduled meeting. Rather,
routine trial activities, such as weekly visits by a member
of the research team to collect completed trial documents
and visits to facilitate information sessions for new or ro-
tating staff, were maintained. These routine trial activities
were ongoing at all three study sites throughout the dur-
ation of recruitment in the trial.
Outcome measures
The primary outcome measures were as follows:
1. Difference in recruitment in each site (A, B and C) from
1 month pre-intervention to 1 month post-intervention
2. Difference in recruitment in each site (A, B and C)
from 3 months pre-intervention to 3 months
post-intervention
The secondary outcome measures were as follows:
1. Change in adherence to trial procedure (defined as
providing eligible women with the trial information
booklet during the antenatal period) in each site (A,
B and C) from 1 month pre-intervention to 1 month
post-intervention.
2. Change in adherence to trial procedure in each site
(A, B and C) from 3 months pre-intervention to 3
months post-intervention.
The 1 month and 3 month timeframes were chosen to
assess short- and long-term effects of the intervention.
Data collection
The data of interest (that is, monthly actual recruitment
rates and adherence to trial procedure) were extracted
from hard copy trial screening and register forms and
from the randomisation service database. The randomisa-
tion service used in the trial was an automated telephone
randomisation service (https://nl.tenalea.net). Randomi-
sations were logged in real time in a central database,
which was password protected and accessible to the lead
research assistant only. All extracted data were entered
into a pre-designed data management table in preparation
for analysis.
Data analysis
Target recruitment rates at each study site had been cal-
culated using a 50% sample population eligibility and as-
suming that 50% of the eligible population would agree
to participate. Due to variations in the sizes of study sites,
target recruitment rates varied between sites. Calculations
were performed from the time point that the SWAT-1
Table 2 Detailed description of the intervention meeting
Detail Description
Date and Time 22 June 2011 at 9am
Attendance 18 clinical staff members directly involved in the recruitment process (that is, distributing information to
potential participants, screening for eligibility and randomising those eligible and consenting). The staff
mix was consultant obstetricians, obstetric registrar, senior house officers and senior midwives (midwifery
managers and staff midwives with greater than 5 year’s clinical experience).
PowerPoint presentation of 10-minute
duration
The content of the presentation included the following: background to the trial, sample size estimates and
monthly recruitment targets, overall recruitment rates across all sites, monthly recruitment rates across all
sites, trends in recruitment with a focus on Site A trends.
Discussion of 20-minute duration Focused on possible reasons for slow recruitment: examples of reasons offered included busyness in the
antenatal clinic impacting on information distribution; mindfulness in remembering to distribute; busyness
in the labour admission room and the time taken to complete the trial screening and register forms and to
obtain consent and randomise participants; and junior staff confidence in recruitment processes and in not
performing an ACTG on those women randomised to IA.
Solutions offered Suggested solutions included a collective and concerted effort to distribute the study information (study
information booklets would subsequently be placed in the consulting rooms in addition to being
distributed as women checked in); reminders from the consultant obstetricians to their obstetric team to
distribute the information; managing the screening process as a usual admission procedure on all women
presenting with signs of labour, and senior midwifery staff supporting junior staff in recruiting participants
to the trial.
Smith et al. Trials  (2015) 16:211 Page 3 of 7
intervention was implemented (that is, 22 June 2011) to
the corresponding monthly dates before and after the
intervention. For example, recruitment proportions 1
month pre-intervention were calculated based on re-
cruitment between 22 May and 21 June inclusive; simi-
larly, recruitment proportions 1 month post-intervention
were calculated based on recruitment between 22 June
and 21 July inclusive. We used the z-score test for propor-
tions to determine any statistically significant difference
in recruitment within Site A, Site B and Site C between
pre-intervention and post-intervention recruitment (Ha:
recruitment pre-intervention < recruitment post-intervention,
alpha 0.05, one-tailed). For between-site differences,
odds ratios (OR) and 95% confidence intervals (CI) were
calculated to compare Site A pre- and post-intervention re-
cruitment and adherence with pre- and post-intervention
recruitment and adherence in Site B + Site C combined.
Ethical approval
Ethical approval was granted for the ADCAR trial by the
Faculty of Health Sciences Research Ethics Committee,
Trinity College Dublin, the Coombe Women and Infant’s
University Hospital Research Ethics Committee, Galway
University Hospitals Clinical Research Ethics Committee
and by the Healthcare Research Advisory Committee,
Health Services Executive, North-East Region. A written
signed consent form was obtained from all participants in
the ADCAR trial prior to inclusion and randomisation.
Ethical approval was not required specifically or in isola-
tion for the site visit because this was a responsive inter-
vention, embedded within the main trial as part of trial
procedure to address slow recruitment.
Results
Figure 1 presents an overview of monthly recruitment
rates, proportionate to target rates, in all three study
sites pre- and post-intervention. The black vertical arrow
indicates the time-point of the intervention.
Table 3 presents recruitment rates, proportionate to
target recruitment, within all three sites, 1 month and 3
months pre- and post-intervention. The percentage point
change and the percentage change in recruitment pre-
and post-intervention are provided.
The analyses demonstrated a 17% and 14% percentage
point increase in recruitment in Site A, respectively, at 1
and at 3 months post-intervention. No statistically sig-
nificant differences (increase or decrease) in recruitment
occurred in Site B or in Site C post-intervention at 1
month or at 3 months.
Comparing between-site differences in recruitment, a
significantly lower rate of recruitment compared to the
target rate was found in Site A (Site A actual recruitment/
target recruitment) compared to Site B + C (Sites B plus
Site C actual recruitment/target recruitment) at 1 month
pre-intervention (13% versus 32%; OR 0.33, 95% CI 0.17
to 0.74). At 1 month post-intervention, this difference was
no longer observed (30% versus 27%; OR 1.15, 0.60 to
2.81) (Figure 2). At 3-months pre-intervention, no statisti-
cally significant difference in recruitment rates in Site A
compared to Site B + C was demonstrated (20% versus
23%; OR 0.82, 95% CI 0.54 to 1.25); however, at 3-months
post-intervention, a statistically significant difference was
detected in favour of higher recruitment in Site A (34%
versus 25%; OR 1.57, 95% CI 1.09 to 2.26) (Figure 2).
Adherence to trial procedure was calculated based on
the number of women screened eligible to participate in
the trial who had received the study information booklet
by the time-point of possible recruitment, divided by the
total number of women screened eligible to participate
in the study (irrespective of whether they participated or
not). These figures were retrieved from the trial screen-
ing and register forms completed just prior to the time-
point of each woman’s potential recruitment. Comparing
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Figure 1 Recruitment rates proportionate to target rates: 2011.
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within-site adherence, the analyses demonstrated a sta-
tistically significant increase in adherence at 1 month
and at 3 months post-intervention in Site A (Table 4).
There was no significant change (reduction or increase)
between pre-intervention and post-intervention adher-
ence rates in Site B and in Site C (Table 4).
Comparing between site differences in adherence rates,
a statistically significantly lower adherence rate in Site
A compared to Site B + C was found at 1 month pre-
intervention (58% versus 78%; OR 0.38, 95% CI 0.16 to
0.94). This difference was not observed at 1 month
post-intervention (82% versus 76%; OR 1.45, 95% CI
0.54 to 3.87) (Figure 3). At 3 months pre-intervention,
a statistically significantly lower adherence to trial proced-
ure was demonstrated in Site A compared to Site B + C
(63% versus 78%; OR 0.36, 95% CI 0.20 to 0.64). Con-
versely, at 3 months post-intervention, adherence was sig-
nificantly higher in Site A compared to Site B + C (87%
versus 78%; OR 1.97, 95% CI 1.04 to 3.76) (Figure 3).
Discussion
In this paper, we provide a SWAT-1 evaluation to inves-
tigate the effects of a site visit combined with a sched-
uled meeting, with the sole purpose of discussing trial
recruitment, on recruitment rates in a large multi-centre
trial. The results provide evidence of benefits from such
a site visit for increasing recruitment rates and adher-
ence to trial procedure at 1 and at 3 months after the
visit. Other studies have also suggested some benefit for
additional communication strategies [5,11]. For example,
Monaghan and colleagues [5] investigated the effect of
different levels of communication between the trial co-
ordination team and participating study sites. Additional
communication involved the addition of frequent emails
to the usual communications, regular personalised mail-
outs of league tables or graphs of performance against
other sites and certificates of achievement for recruit-
ment. This was compared to usual communication pro-
vided via the regional centre, which involved occasional
direct communications in the form of generic newslet-
ters, emails or faxes. At the end of recruitment, there
was no significant difference in the median number of
participants randomised in each centre in the two groups
(37.5 versus 37.0, P = 0.68). The median time to half
randomisation target was non-significantly lower in the
additional communication group compared to the usual
group (4.4 months versus 5.8 months, P = 0.08), which
suggests that an additional communication strategy may
be of some, albeit non-statistically significant, incremental
benefit in helping sites achieve recruitment targets sooner.
In our SWAT-1, the additional communication strategy
involved a personalised site visit, suggesting perhaps that
Table 3 Recruitment pre- and post-intervention
Site and time-point Pre-intervention Post-intervention Change from pre- to post-intervention
% of target (n/n = actual/target) % of target (n/n = actual/target) % point change % change P value
Site A at 1 month 13% (8/60) 30% (18/60) +17% 125% 0.01
Site A at 3 months 20% (36/180) 34% (61/180) +14% 69% 0.002
Site B at 1 month 27% (32/120) 19% (23/120) - 8% 39% 0.08
Site B at 3 months 14% (50/360) 18% (65/360) +4% 30% 0.06
Site C at 1 month 42% (25/60) 43% (26/60) +1% 4% 0.43
Site C at 3 months 42% (76/180) 38% (60/180) - 4% 11% 0.23
Subgroup
1 month pre-intervention
SWAT I
1 month post-intervention
SWAT I
3 months pre-intervention
SWAT I
3 months post-intervention
SWAT I
Events
8
18
36
61
Total
60
60
180
180
Events
57
49
126
133
Total
180
180
540
540
M-H, Fixed, 95% CI
0.33 [0.15, 0.74]
1.15 [0.60, 2.18]
0.82 [0.54, 1.25]
1.57 [1.09, 2.26]
Experimental Control Odds Ratio Odds Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours Site B+C Favours Site A
Figure 2 Comparison of actual versus target recruitment in site A versus B + C at 1 and 3 months pre- and post-intervention.
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face-to-face additional communication might confer more
benefit in assisting boost recruitment rates in a trial com-
pared to non-face-to-face strategies.
There are some limitations associated with this imple-
mentation of SWAT-1 that need to be acknowledged
when considering our results. Firstly, although recruitment
rates had been less than expected at all three sites, month-
end recruitment at the intervention site had fallen consid-
erably and consistently in the months before the site visit
and meeting. Therefore, this site was purposively chosen
for the intervention, rather than randomly assigned. This
lack of randomisation introduces the potential for bias.
Secondly, there is a risk that other confounding factors
might have influenced the results. For example, regular
weekly visits by a member of the research team were on-
going for all three sites throughout the trial, including the
intervention site, Site A. This makes it difficult to disentan-
gle the effect that these routine activities might have had
on the findings of our study. For example, one might ques-
tion as to whether the targeted site visit alone caused
the increase in recruitment at 1 and 3 months post-
intervention at Site A or whether the targeted site visit
increased the impact of the routine visits, such that this
combination caused the effect. Thirdly, adherence to
trial procedure was evaluated based on information avail-
able from completed trial screening and register forms but
the accuracy of these findings is dependent on the com-
pleteness of reporting of these forms. We cannot be cer-
tain that forms were completed on all potentially eligible
women; that is, those who did not receive the study infor-
mation and those who did receive it but did not agree to
join the study. Therefore, the results of this analysis
should be treated with caution. Furthermore, just prior to
implementing the intervention, Site A had taken a down-
turn in recruitment with a subsequent upturn, while Site
B and Site C had taken an upturn with a subsequent
downturn (Figure 1), consistent with regression to the
mean. However, it is worth noting that, for Site A, recruit-
ment is maintained long-term at a considerably higher
rate than pre-intervention, which is promising. Finally,
this SWAT-1 evaluation uses a retrospective design in
which the occurrence of the intervention was combined
with recruitment rates sometime after the site visit and
meeting. Ideally, to enhance rigour, SWAT-1 should be
prospectively implemented and include random allocation
of study sites to intervention and control. However, ran-
domisation is not always possible and a before and after
evaluation is worthwhile. If several before and after studies
all show a similar effect, it might be reasonable to consider
that this is evidence of benefit.
Recognising these limitations, our study does provide
some evidence for the effectiveness of a site visit combined
Table 4 Adherence to trial procedure pre- and post-intervention
Site and time-point Pre-intervention (number screened eligible who
received study information/total screened eligible)
Pre-intervention (number screened eligible who
received study information/total screened eligible)
P value
Site A at 1 month 58% (15/26) 82% (28/34) 0.02
Site A at 3 months 63% (45/72) 87% (90/103) <0.0001
Site B at 1 month 68% (49/72) 72% (54/75) 0.30
Site B at 3 months 66% (107/163) 72% (137/189) 0.08
Site C at 1 month 95% (40/42) 85% (33/39) 0.55
Site C at 3 months 90% (106/118) 88% (84/95) 0.37
Subgroup
1 month pre-intervention
SWAT I
1 month post-intervention
SWAT I
3 months pre-intervention
SWAT I
3 months post-intervention
SWAT I
Events
15
28
45
90
Total
26
34
72
103
Events
89
87
231
221
Total
114
114
284
284
M-H, Fixed, 95% CI
0.38 [0.16, 0.94]
1.45 [0.54, 3.87]
0.38 [0.22, 0.67]
1.97 [1.04, 3.76]
Experimental Control Odds Ratio Odds Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours Site B+C Favours Site A
Figure 3 Comparison of adherence between site A and B + C at 1 and 3 months pre- and post-intervention.
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with a scheduled meeting on recruitment rates and adher-
ence to trial procedure in a multi-centre randomised trial.
More importantly, perhaps, our study demonstrates the
potential value of using SWAT-1 to evaluate, pragmatically,
what works when attempting to tackle the problem of
poor recruitment to a trial. Based on our results, other
researchers might also be encouraged to implement
SWAT-1, or their own version of it, if they are facing
similar problems of slow or poor recruitment in their
trials. As the findings from further SWAT-1 s become
available, the results could be combined in cumulative
meta-analyses [12], which will provide increased power
to estimate the effects of a site visit by the lead researcher
or principal investigator on recruitment in multi-centre
trials, and to compare and contrast the findings in differ-
ent settings.
Conclusions
This paper provides the first reported example of a study
in the SWAT programme, using the SWAT-1 design. It
provides some evidence that a targeted site visit com-
bined with a purposeful meeting increases recruitment
rates and adherence to trial procedure in a clinical trial.
We hope that this example of SWAT-1 might encourage
other researchers to consider conducting a similar study
to improve recruitment in their trials, allowing the find-
ings of future SWAT-1 s to be compared, contrasted and
combined so that higher level evidence on the effect of a
site visit by the lead researcher or principal investigator
can be obtained.
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